Management of penicillamine nephropathy in Wilson's disease: a new chelating agent.

Walshe, J M

Management of penicillamine nephropathy in Wilson's disease: a new chelating agent. [electronic resource] - Lancet (London, England) Dec 1969 - 1401-2 p. digital

Publication Type: Journal Article

0140-6736

10.1016/s0140-6736(69)90940-4 doi


Adolescent
Chelating Agents--therapeutic use
Chlorides
Copper--metabolism
Ethylenediamines--therapeutic use
Hepatolenticular Degeneration--drug therapy
Humans
Male
Nephrotic Syndrome--chemically induced
Neurologic Manifestations
Penicillamine--adverse effects